title: Predictors of conversion of atrial fibrillation after cardiac operation in the absence of class I or III antiarrhythmic medications.
abstract: BACKGROUND
  Although risk factors for the development of atrial fibrillation (AF) after cardiac operations have been studied extensively, predictors of conversion to sinus rhythm within 24 hours of onset have not been examined.
  
  
  METHODS
  Eleven hundred consecutive adults undergoing cardiovascular operations from July 1997 to June 1998 were screened for new onset AF after operation. Patients with chronic persistent preoperative AF or those who died within 48 hours of the operation were excluded.
  
  
  RESULTS
  Three hundred fifty-three patients develop
authors.affiliation: The Hoffman Heart Institute, St. Francis Hospital and Medical Center, Hartford, Connecticut 06105, USA. rsoucier@stfranciscare.org
authors.forename: R J
authors.initials: RJ
authors.lastname: Soucier
authors.forename: S
authors.initials: S
authors.lastname: Mirza
authors.forename: M G
authors.initials: MG
authors.lastname: Abordo
authors.forename: E
authors.initials: E
authors.lastname: Berns
authors.forename: H C
authors.initials: HC
authors.lastname: Dalamagas
authors.forename: A
authors.initials: A
authors.lastname: Hanna
authors.forename: D I
authors.initials: DI
authors.lastname: Silverman
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000704:Analysis of Variance; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D004077:Digoxin / Q000627:therapeutic use; D005260:Female; D006339:Heart Rate; D006801:Humans; D016015:Logistic Models; D008297:Male; D011446:Prospective Studies; D013997:Time Factors
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D004077:Digoxin